Mackay, H., Buckanovich, R., Hirte, H., Correa, R., Hoskins, P., Biagi, J., . . . Oza, A. (2011). A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia.
استشهاد بنمط شيكاغوMackay, HJ, et al. A Phase II Study Single Agent of Aflibercept (VEGF Trap) in Patients With Recurrent or Metastatic Gynecologic Carcinosarcomas and Uterine Leiomyosarcoma. A Trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia. 2011.
MLA استشهادMackay, HJ, et al. A Phase II Study Single Agent of Aflibercept (VEGF Trap) in Patients With Recurrent or Metastatic Gynecologic Carcinosarcomas and Uterine Leiomyosarcoma. A Trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia. 2011.